These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 34454862)

  • 1. The future of COVID-19: A vaccine review.
    Vashi AP; Coiado OC
    J Infect Public Health; 2021 Oct; 14(10):1461-1465. PubMed ID: 34454862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Community Partnered Approach to Promoting COVID-19 Vaccine Equity.
    Scott T; Gutschow B; Ragavan MI; Ho K; Massart M; Ripper L; Muthama V; Miller E; Bey J; Abernathy RP
    Health Promot Pract; 2021 Nov; 22(6):758-760. PubMed ID: 34311592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral and social science in support of SARS-CoV-2 vaccination: National Institutes of Health initiatives.
    Hunter CM; Chou WS; Webb Hooper M
    Transl Behav Med; 2021 Jul; 11(7):1354-1358. PubMed ID: 34080616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of Traditional Vaccine Development Strategies to SARS-CoV-2.
    Rando HM; Lordan R; Lee AJ; Naik A; Wellhausen N; Sell E; Kolla L; ; Gitter A; Greene CS
    mSystems; 2023 Apr; 8(2):e0092722. PubMed ID: 36861991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot recruitment strategy to enhance ethical and equitable access to Covid-19 pediatric vaccine trials.
    Muller WJ; Jhaveri R; Heald-Sargent T; Macy ML; Heard-Garris N; Shah S; Paquette E
    Clin Trials; 2024 Jun; 21(3):390-396. PubMed ID: 38140914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solidarity across borders: A pragmatic need for global COVID-19 vaccine equity.
    Obinna DN
    Int J Health Plann Manage; 2022 Jan; 37(1):21-29. PubMed ID: 34585430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 variants and COVID-19 vaccines: Current challenges and future strategies.
    Gong W; Parkkila S; Wu X; Aspatwar A
    Int Rev Immunol; 2023; 42(6):393-414. PubMed ID: 35635216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants.
    Zhang J; Han ZB; Liang Y; Zhang XF; Jin YQ; Du LF; Shao S; Wang H; Hou JW; Xu K; Lei W; Lei ZH; Liu ZM; Zhang J; Hou YN; Liu N; Shen FJ; Wu JJ; Zheng X; Li XY; Li X; Huang WJ; Wu GZ; Su JG; Li QM
    Elife; 2022 Aug; 11():. PubMed ID: 36004719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccines for a healthy future: 21st DCVMN Annual General Meeting 2020 report.
    Pagliusi S; Hayman B; Jarrett S
    Vaccine; 2021 Apr; 39(18):2479-2488. PubMed ID: 33838948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed Access to COVID-19 Vaccines: A Perspective on Low-income Countries in Africa.
    Hassan MA; Aliyu S
    Int J Health Serv; 2022 Jul; 52(3):323-329. PubMed ID: 35469499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactive, on-line visualization tools to measure and drive equity in COVID-19 vaccine administrations.
    Shaheen AW; Ciesco E; Johnson K; Kuhnen G; Paolini C; Gartner G
    J Am Med Inform Assoc; 2021 Oct; 28(11):2451-2455. PubMed ID: 34480569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccines against SARS-CoV-2 variants and future pandemics.
    Park T; Hwang H; Moon S; Kang SG; Song S; Kim YH; Kim H; Ko EJ; Yoon SD; Kang SM; Hwang HS
    Expert Rev Vaccines; 2022 Oct; 21(10):1363-1376. PubMed ID: 35924678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allocating a COVID-19 Vaccine: Balancing National and International Responsibilities.
    Lie RK; Miller FG
    Milbank Q; 2021 Jun; 99(2):450-466. PubMed ID: 33295679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 testing disparities across geographical regions from a large metropolitan area in Brazil: Results from a web-based survey among individuals interested in clinical trials for COVID-19 vaccines.
    Torres TS; Luz PM; Coelho LE; Jalil C; Falco GG; Sousa LP; Jalil E; Bezerra DRB; Cardoso SW; Hoagland B; Struchiner CJ; Veloso VG; Grinsztejn B
    Braz J Infect Dis; 2021; 25(4):101600. PubMed ID: 34375647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid Transition to Telehealth and the Digital Divide: Implications for Primary Care Access and Equity in a Post-COVID Era.
    Chang JE; Lai AY; Gupta A; Nguyen AM; Berry CA; Shelley DR
    Milbank Q; 2021 Jun; 99(2):340-368. PubMed ID: 34075622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. At-home testing to mitigate community transmission of SARS-CoV-2: protocol for a public health intervention with a nested prospective cohort study.
    Ciccone EJ; Conserve DF; Dave G; Hornik CP; Kuhn ML; Herling JL; Song M; Alston S; Singler L; Schmidt MD; Jones A; Broderick S; Wruck LM; Kibbe WA; Aiello AE; Woods CW; Richmond A; Cohen-Wolkowiez M; Corbie-Smith G
    BMC Public Health; 2021 Dec; 21(1):2209. PubMed ID: 34863144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccines and allergic reactions: The past, the current COVID-19 pandemic, and future perspectives.
    Sampath V; Rabinowitz G; Shah M; Jain S; Diamant Z; Jesenak M; Rabin R; Vieths S; Agache I; Akdis M; Barber D; Breiteneder H; Chinthrajah S; Chivato T; Collins W; Eiwegger T; Fast K; Fokkens W; O'Hehir RE; Ollert M; O'Mahony L; Palomares O; Pfaar O; Riggioni C; Shamji MH; Sokolowska M; Jose Torres M; Traidl-Hoffmann C; van Zelm M; Wang Y; Zhang L; Akdis CA; Nadeau KC
    Allergy; 2021 Jun; 76(6):1640-1660. PubMed ID: 33811364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Socialized and traumatized: Pharmacists, underserved patients, and the COVID-19 vaccine.
    Riley AC; Campbell H; Butler L; Wisseh C; Nonyel NP; Shaw TE
    J Am Pharm Assoc (2003); 2021; 61(6):e2-e5. PubMed ID: 34147364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccines for COVID-19: A Systematic Review of Immunogenicity, Current Development, and Future Prospects.
    Zhang Z; Shen Q; Chang H
    Front Immunol; 2022; 13():843928. PubMed ID: 35572592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.